- Written communication relating to an issuer or third party (SC TO-C)
16 Mayo 2011 - 11:34AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of
1934
Date of Report (Date of earliest event reported): May 16, 2011
STRYKER CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Michigan
|
|
0-9165
|
|
38-1239739
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
2825 Airview Boulevard, Kalamazoo, Michigan
|
|
49002
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (269) 385-2600
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
x
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
On May 16, 2011,
Stryker Corporation announced that it has entered into a definitive agreement to acquire Orthovita, Inc. through an all cash tender offer. Under the terms of the agreement, Orthovita shareholders will receive $3.85 for each outstanding Orthovita
share of common stock. The value of the transaction is estimated at $316 million, based upon Orthovitas 79 million fully diluted shares outstanding as well as net debt of $12 million. The closing of the transaction is subject to
expiration or termination of the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions. A copy of the press release announcing the agreement is attached hereto as Exhibit 99.1 and
incorporated herein by reference.
Item 9.01
|
Financial Statements and Exhibits
|
99.1 Press release
dated May 16, 2011
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
STRYKER CORPORATION
|
|
|
|
|
/s/ Curt R. Hartman
|
Date
May 16, 2011
|
|
Curt R. Hartman
|
|
|
Vice President and Chief Financial Officer
|
3
Exhibit Index
|
|
|
Exhibit
|
|
Description
|
|
|
99.1
|
|
Press release dated May 16, 2011
|
4
Orthovita, Inc. (MM) (NASDAQ:VITA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Orthovita, Inc. (MM) (NASDAQ:VITA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Orthovita, Inc. (MM) (NASDAQ): 0 recent articles
Más de Artículos de Noticias